SU‐E‐T‐159: Development of An Independent, Monte Carlo, Dose Calculation, Quality Assurance Tool for Clinical Trials
A. Faught, S. Davidson, J. Fontenot, S. Kry, C. Etzel, G. Ibbott, D. Followill
Purpose: To commission a multiple‐source Monte Carlo model of Elekta linear accelerator beams of nominal energies 6MV and 10MV. Methods: A three source, Monte Carlo model of Elekta 6 and 10MV therapeutic x‐ray beams was developed in a two‐step process. Energy spectra of each of three sources, a primary source corresponding to photons created in the target, an extra‐focal source corresponding to photons originating from scattered events in the linac head, and an electron contamination source, were determined. The two photon sources were determined by an optimization process that fit the relative fluence of 0.25 MeV energy bins to the product of Fatigue‐Life and Fermi functions to match calculated percent depth dose (PDD) data with that measured in water for a 10×10cm2 field. Off‐axis effects were modeled by fitting the off‐axis fluence to a piece‐wise linear function through optimization of relative fluence to match calculated dose profiles with measured dose profiles for a 40×40cm2 field. A 3rd degree polynomial was used to describe the off‐axis half‐value layer as a function of off‐axis angle. The model was then commissioned by comparing calculated PDDs and dose profiles for field sizes ranging from 3×3cm2 to 30×30cm2 to those obtained from measurements. Results: Agreement between calculated and measured data was evaluated using 2%/2mm global gamma criterion for field sizes of 3×3, 5×5, 10×10, 15×15, 20×20, and 30×30cm2. Along the central axis of the beam 99.5% and 99.6% of all data passed the criterion for 6 and 10MV models, respectively. Dose profiles at depths of dmax, 5, 10, 20, and 25cm agreed with measured data for 95.4% and 99.2% of data tested for 6 and 10MV models, respectively. Conclusion: A Monte Carlo multiple‐source model for Elekta 6 and 10MV therapeutic x‐ray beams has been developed as a quality assurance tool for clinical trials. This work was supported by Public Health Service grants CA010953, CA081647, and CA21661 awarded by the National Cancer Institute, United States Department of Health and Human Services.
Dive into the research topics of 'SU‐E‐T‐159: Development of An Independent, Monte Carlo, Dose Calculation, Quality Assurance Tool for Clinical Trials'. Together they form a unique fingerprint.
Photons Medicine & Life Sciences 100%
Clinical Trials Medicine & Life Sciences 61%
X-Rays Medicine & Life Sciences 48%
United States Dept. of Health and Human Services Medicine & Life Sciences 44%
Particle Accelerators Medicine & Life Sciences 41%
United States Public Health Service Medicine & Life Sciences 38%
Organized Financing Medicine & Life Sciences 37%
National Cancer Institute (U.S.) Medicine & Life Sciences 36%
Faught, A., Davidson, S., Fontenot, J., Kry, S., Etzel, C., Ibbott, G., & Followill, D. (2013). SU‐E‐T‐159: Development of An Independent, Monte Carlo, Dose Calculation, Quality Assurance Tool for Clinical Trials. Medical Physics, 40(6), 240. https://doi.org/10.1118/1.4814594
SU‐E‐T‐159 : Development of An Independent, Monte Carlo, Dose Calculation, Quality Assurance Tool for Clinical Trials. / Faught, A.; Davidson, S.; Fontenot, J. et al.
In: Medical Physics, Vol. 40, No. 6, 06.2013, p. 240.
Faught, A, Davidson, S, Fontenot, J, Kry, S, Etzel, C, Ibbott, G & Followill, D 2013, 'SU‐E‐T‐159: Development of An Independent, Monte Carlo, Dose Calculation, Quality Assurance Tool for Clinical Trials', Medical Physics, vol. 40, no. 6, pp. 240. https://doi.org/10.1118/1.4814594
Faught A, Davidson S, Fontenot J, Kry S, Etzel C, Ibbott G et al. SU‐E‐T‐159: Development of An Independent, Monte Carlo, Dose Calculation, Quality Assurance Tool for Clinical Trials. Medical Physics. 2013 Jun;40(6):240. doi: 10.1118/1.4814594
Faught, A. ; Davidson, S. ; Fontenot, J. et al. / SU‐E‐T‐159 : Development of An Independent, Monte Carlo, Dose Calculation, Quality Assurance Tool for Clinical Trials. In: Medical Physics. 2013 ; Vol. 40, No. 6. pp. 240.
@article{bcb5d7d6748a4903bfe9e1e57ce125da,
title = "SU‐E‐T‐159: Development of An Independent, Monte Carlo, Dose Calculation, Quality Assurance Tool for Clinical Trials",
abstract = "Purpose: To commission a multiple‐source Monte Carlo model of Elekta linear accelerator beams of nominal energies 6MV and 10MV. Methods: A three source, Monte Carlo model of Elekta 6 and 10MV therapeutic x‐ray beams was developed in a two‐step process. Energy spectra of each of three sources, a primary source corresponding to photons created in the target, an extra‐focal source corresponding to photons originating from scattered events in the linac head, and an electron contamination source, were determined. The two photon sources were determined by an optimization process that fit the relative fluence of 0.25 MeV energy bins to the product of Fatigue‐Life and Fermi functions to match calculated percent depth dose (PDD) data with that measured in water for a 10×10cm2 field. Off‐axis effects were modeled by fitting the off‐axis fluence to a piece‐wise linear function through optimization of relative fluence to match calculated dose profiles with measured dose profiles for a 40×40cm2 field. A 3rd degree polynomial was used to describe the off‐axis half‐value layer as a function of off‐axis angle. The model was then commissioned by comparing calculated PDDs and dose profiles for field sizes ranging from 3×3cm2 to 30×30cm2 to those obtained from measurements. Results: Agreement between calculated and measured data was evaluated using 2%/2mm global gamma criterion for field sizes of 3×3, 5×5, 10×10, 15×15, 20×20, and 30×30cm2. Along the central axis of the beam 99.5% and 99.6% of all data passed the criterion for 6 and 10MV models, respectively. Dose profiles at depths of dmax, 5, 10, 20, and 25cm agreed with measured data for 95.4% and 99.2% of data tested for 6 and 10MV models, respectively. Conclusion: A Monte Carlo multiple‐source model for Elekta 6 and 10MV therapeutic x‐ray beams has been developed as a quality assurance tool for clinical trials. This work was supported by Public Health Service grants CA010953, CA081647, and CA21661 awarded by the National Cancer Institute, United States Department of Health and Human Services.",
author = "A. Faught and S. Davidson and J. Fontenot and S. Kry and C. Etzel and G. Ibbott and D. Followill",
journal = "Medical Physics",
publisher = "AAPM - American Association of Physicists in Medicine",
T1 - SU‐E‐T‐159
T2 - Development of An Independent, Monte Carlo, Dose Calculation, Quality Assurance Tool for Clinical Trials
AU - Faught, A.
AU - Davidson, S.
AU - Fontenot, J.
AU - Kry, S.
AU - Etzel, C.
AU - Ibbott, G.
AU - Followill, D.
N2 - Purpose: To commission a multiple‐source Monte Carlo model of Elekta linear accelerator beams of nominal energies 6MV and 10MV. Methods: A three source, Monte Carlo model of Elekta 6 and 10MV therapeutic x‐ray beams was developed in a two‐step process. Energy spectra of each of three sources, a primary source corresponding to photons created in the target, an extra‐focal source corresponding to photons originating from scattered events in the linac head, and an electron contamination source, were determined. The two photon sources were determined by an optimization process that fit the relative fluence of 0.25 MeV energy bins to the product of Fatigue‐Life and Fermi functions to match calculated percent depth dose (PDD) data with that measured in water for a 10×10cm2 field. Off‐axis effects were modeled by fitting the off‐axis fluence to a piece‐wise linear function through optimization of relative fluence to match calculated dose profiles with measured dose profiles for a 40×40cm2 field. A 3rd degree polynomial was used to describe the off‐axis half‐value layer as a function of off‐axis angle. The model was then commissioned by comparing calculated PDDs and dose profiles for field sizes ranging from 3×3cm2 to 30×30cm2 to those obtained from measurements. Results: Agreement between calculated and measured data was evaluated using 2%/2mm global gamma criterion for field sizes of 3×3, 5×5, 10×10, 15×15, 20×20, and 30×30cm2. Along the central axis of the beam 99.5% and 99.6% of all data passed the criterion for 6 and 10MV models, respectively. Dose profiles at depths of dmax, 5, 10, 20, and 25cm agreed with measured data for 95.4% and 99.2% of data tested for 6 and 10MV models, respectively. Conclusion: A Monte Carlo multiple‐source model for Elekta 6 and 10MV therapeutic x‐ray beams has been developed as a quality assurance tool for clinical trials. This work was supported by Public Health Service grants CA010953, CA081647, and CA21661 awarded by the National Cancer Institute, United States Department of Health and Human Services.
AB - Purpose: To commission a multiple‐source Monte Carlo model of Elekta linear accelerator beams of nominal energies 6MV and 10MV. Methods: A three source, Monte Carlo model of Elekta 6 and 10MV therapeutic x‐ray beams was developed in a two‐step process. Energy spectra of each of three sources, a primary source corresponding to photons created in the target, an extra‐focal source corresponding to photons originating from scattered events in the linac head, and an electron contamination source, were determined. The two photon sources were determined by an optimization process that fit the relative fluence of 0.25 MeV energy bins to the product of Fatigue‐Life and Fermi functions to match calculated percent depth dose (PDD) data with that measured in water for a 10×10cm2 field. Off‐axis effects were modeled by fitting the off‐axis fluence to a piece‐wise linear function through optimization of relative fluence to match calculated dose profiles with measured dose profiles for a 40×40cm2 field. A 3rd degree polynomial was used to describe the off‐axis half‐value layer as a function of off‐axis angle. The model was then commissioned by comparing calculated PDDs and dose profiles for field sizes ranging from 3×3cm2 to 30×30cm2 to those obtained from measurements. Results: Agreement between calculated and measured data was evaluated using 2%/2mm global gamma criterion for field sizes of 3×3, 5×5, 10×10, 15×15, 20×20, and 30×30cm2. Along the central axis of the beam 99.5% and 99.6% of all data passed the criterion for 6 and 10MV models, respectively. Dose profiles at depths of dmax, 5, 10, 20, and 25cm agreed with measured data for 95.4% and 99.2% of data tested for 6 and 10MV models, respectively. Conclusion: A Monte Carlo multiple‐source model for Elekta 6 and 10MV therapeutic x‐ray beams has been developed as a quality assurance tool for clinical trials. This work was supported by Public Health Service grants CA010953, CA081647, and CA21661 awarded by the National Cancer Institute, United States Department of Health and Human Services.
JO - Medical Physics
JF - Medical Physics